Esophageal Cancer
Conditions
Keywords
Chinese, esophageal cancer, surgeries of Ivor-Lewis/Mckeown
Brief summary
The study was designed to compare effectiveness and safety of the surgeries of Ivor-Lewis and Mckeown in patients with esophageal cancer
Detailed description
The trial is a multi-centre real-world non-interventional observational study. The study was designed to compare effectiveness and safety of the minimally invasive surgeries of Ivor-Lewis and Mckeown in the Chinese patients with IA-IIIB esophageal cancer via a retrospectively review method based on the study data on patient demographic/tumor biological characteristics and clinical treatments.
Interventions
PROCEDURESurgeries
Minimally invasive surgeries of Ivor-Lewis and Mckeown
Sponsors
LinkDoc Technology (Beijing) Co. Ltd.
Chinese PLA General Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Pathologically diagnosed middle and lower thoracic IA-IIIB esophageal cancer after surgeries; * Patients who received minimally invasive radical dissections of Ivor-Lewis and Mckeown; * Patients who received tubular gastroesophageal reconstruction;
Exclusion criteria
* Patients complicated with arrhythmia, or serious disfunctions of heart, lung, liver, and kidney before surgeries; * Patients with second primary tumors; * Patients who received abdominal or thoracic surgeries; * Patients who received gastrostomy or nesteostomy before surgeries; * Patients with suspected cervical lymph metastases (in the subgroup of the patients who received the surgery of Mckeown)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall survivals in patients with esophageal cancer who received surgeries | 2010 - 2017 | Overall survivals in patients with esophageal cancer who received surgeries categorised by tumor biological characteristics |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Death rates within 30 days after surgeries | 2010 - 2017 | Death rates within 30 days after surgeries categorised by tumor biological characteristics |
Other
| Measure | Time frame | Description |
|---|---|---|
| Incidence of complications after surgeries | 2010 - 2017 | Incidence of complications after surgeries categorised by tumor biological characteristics |
| Incision R0 rates | 2010 - 2017 | Incision R0 rates categorised by tumor biological characteristics |
| Percentages of patients who received lymphadenectomy | 2010 - 2017 | Percentages of patients who received lymphadenectomy categorised by tumor biological characteristics |
| Extents of lymph metastases | 2010 - 2017 | Extents of lymph metastases categorised by tumor biological characteristics |
Countries
China
Outcome results
None listed